Alzamend Neuro™ Appoints New CEO, Bio-Pharma Executive Stephan Jackman
20 nov. 2018 09h00 HE
|
Alzamend Neuro, Inc.
Salt Lake City, Nov. 20, 2018 (GLOBE NEWSWIRE) -- Alzamend Neuro™, Inc. (Alzamend™ or the “Company”) announced today that it has appointed bio-pharma executive, Mr. Stephan Jackman, as its new Chief...
Alzamend Neuro™ Secures New Licenses from USF to Treat Alzheimer’s Disease
29 oct. 2018 09h00 HE
|
Alzamend Neuro, Inc.
Salt Lake City, UT, Oct. 29, 2018 (GLOBE NEWSWIRE) -- Alzamend Neuro™, Inc. (Alzamend™ or the “Company”) announced today that it secured two new licenses from the University of South Florida (“USF”)...